Groowe Groowe / Newsroom / IBIO
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IBIO News

iBio, Inc. Common Stock

Urothelial Carcinoma Market in the 7MM to 2036: 206,300 Incident Cases in 2025 as ADC-Immunotherapy Combos Reshape Care

globenewswire.com
BMY PFE AZN TYRA JNJ IBIO

Form 8-K

sec.gov
IBIO

Form 8-K

sec.gov
IBIO

iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610’s Potential to Preserve Muscle in Combination with GLP-1 Therapy

globenewswire.com
IBIO

Global Immunotherapy Drugs Market - Size, Share, Trends, Competitive Landscape, and Forecast - 2034 | Market to Reach USD 837.14 Billion as Cell Therapies Drive 13.05% CAGR

globenewswire.com
MRK BMY NVS ROG AMGN IBIO AZN JNJ GSK IOVA ABBV

Immorta Bio, a Scientific Longevity Company, Selected for NYU Stern's Prestigious Endless Frontier Labs 2026-27 Life Sciences Cohort

prnewswire.com
IBIO

Form 8-K

sec.gov
IBIO

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

globenewswire.com
IBIO

Form 8-K

sec.gov
IBIO

iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

globenewswire.com
IBIO